News + Filings Transactions
|
MOATAZEDI DAVID
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/16/2023 | Evolus, Inc. | EOLS | Sale | Common Stock | 14.8k | $10.27 | $151.8k | | 08/14/2023 |
| 08/14/2023 | Evolus, Inc. | EOLS | Grant | Common Stock | 91.8k | $0.00 | $0 | | 08/14/2023 |
| 05/08/2023 | Evolus, Inc. | EOLS | Grant | Restricted Stock Units | 560k | $0.00 | $0 | | 05/08/2023 |
| 03/14/2023 | Evolus, Inc. | EOLS | Sale | Common Stock | 64.2k | $8.47 | $543.8k | | 03/14/2023 |
| 01/25/2023 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 257k | $11.04 | $2.8M | | 01/25/2023 |
| 01/25/2023 | Evolus, Inc. | EOLS | Grant | Common Stock | 187.9k | $0.00 | $0 | | 01/25/2023 |
| 05/16/2022 | Evolus, Inc. | EOLS | Sale | Common Stock | 55.3k | $13.64 | $754.3k | | 05/16/2022 |
| 03/28/2022 | Evolus, Inc. | EOLS | Sale | Common Stock | 6.1k | $11.62 | $70.9k | | 03/28/2022 |
| 03/08/2022 | Evolus, Inc. | EOLS | Sale | Common Stock | 38k | $9.73 | $369.3k | | 03/08/2022 |
| 01/24/2022 | Evolus, Inc. | EOLS | Grant | Common Stock | 214.3k | $0.00 | $0 | | 01/24/2022 |
| 01/24/2022 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 310.6k | $5.46 | $1.7M | | 01/24/2022 |
| 08/16/2021 | Evolus, Inc. | EOLS | Sale | Common Stock | 47.7k | $11.35 | $541.7k | | 08/13/2021 |
| 08/13/2021 | Evolus, Inc. | EOLS | Sale | Common Stock | 22.7k | $10.66 | $242.1k | | 08/13/2021 |
| 08/10/2021 | Evolus, Inc. | EOLS | Sale | Common Stock | 41.8k | $11.18 | $466.8k | | 08/10/2021 |
| 08/10/2021 | Evolus, Inc. | EOLS | Sale | Common Stock | 41.8k | $11.18 | $466.8k | | 08/10/2021 |
| 03/26/2021 | Evolus, Inc. | EOLS | Grant | Common Stock | 48.9k | $0.00 | $0 | | 03/26/2021 |
| 01/27/2021 | Evolus, Inc. | EOLS | Grant | Common Stock | 266.7k | $0.00 | $0 | | 01/27/2021 |
| 01/25/2021 | Evolus, Inc. | EOLS | Sale | Common Stock | 8.3k | $7.46 | $62k | | 01/25/2021 |
| 05/13/2020 | Evolus, Inc. | EOLS | Grant | Common Stock | 100k | $0.00 | $0 | | 05/13/2020 |
| 01/23/2020 | Evolus, Inc. | EOLS | Grant | Common Stock | 82.1k | $0.00 | $0 | | 01/23/2020 |
| 01/23/2020 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 141.9k | $10.19 | $1.4M | | 01/23/2020 |
| 07/23/2019 | ReShape Lifesciences Inc. | OBLN | Grant | Common Stock (Restricted Stock Units) | 78.1k | $0.00 | $0 | | 07/23/2019 |
| 01/23/2019 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 125k | $16.19 | $2M | | 01/23/2019 |
| 08/23/2018 | ReShape Lifesciences Inc. | OBLN | Grant | Common Stock | 5.5k | $1.82 | $10k | | 08/23/2018 |
| 06/13/2018 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (Right to Buy) | 81.8k | $2.36 | $193k | | 06/13/2018 |
| 06/13/2018 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (Right to Buy) | 81.8k | $2.36 | $193k | | 06/13/2018 |
| 05/06/2018 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 1.2M | $7.28 | $8.6M | | 05/06/2018 |
| 06/06/2017 | ReShape Lifesciences Inc. | OBLN | Grant | Stock Option (Right to Buy) | 36.6k | $9.81 | $358.6k | | 06/06/2017 |
|